The pharmaceutical industry is bracing for growth and regulatory challenges this year, led by major companies like Novo Nordisk and AstraZeneca. On Wednesday, Novo Nordisk announced an increase in emissions due to skyrocketing growth, driven primarily by its obesity drug Wegovy. To meet growing demand, the company is ramping up production investments significantly.
About the Author
